Reverse phase partition HPLC for determination of plasma purines and pyrimidines in subjects with gout and renal failure.
A reverse phase partition mode of high pressure liquid chromatography was developed for the estimation of purine, pyrimidine and pyrazolopyrimidine nucleosides and bases. This method has been applied to the investigation of purine and pyrimidine metabolism in subjects with gout and/or renal failure during allopurinol therapy. Plasma levels of hypoxanthine and xanthine were quantitated in all subjects. No significant differences were observed between healthy males and gouty subjects with or without allopurinol medication. There was a significant increase in xanthine levels in patients with gout and renal failure, or renal failure on allopurinol, and plasma levels of oxipurinol were increased, but no correlation with glomerular filtration rate (GFR) was observed. The separation method was also used to examine urines from patients with known abnormalities of purine and pyrimidine metabolism in an attempt to evaluate its usefulness as a urine screening technique.
D058186:Acute Kidney Injury / Q000097:blood* / Q000188:drug therapy; D000493:Allopurinol / Q000627:therapeutic use; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004032:Diet; D006073:Gout / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D008297:Male; D011687:Purines / Q000097:blood* / Q000652:urine; D011743:Pyrimidines / Q000097:blood* / Q000652:urine
D011687:Purines; D011743:Pyrimidines; D000493:Allopurinol